bluebird bio Receives $30,000,000 Series C Financing Round

  • Feed Type
  • Date
    4/20/2011
  • Company Name
    bluebird bio
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options.
  • Website
    http://www.bluebirdbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The funds will be used to focus on driving forward the company’s clinical trials while strategically investing in its pipeline and core product platform capabilities.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    TVM Capital
  • Venture Investor
    Forbion Capital Partners
  • Venture Investor
    Easton Capital

By posting a comment, you agree to our terms and conditions.